Agilent Technologies Finds GAAP Profitability, Life Sciences Group Reports Record Orders | GenomeWeb

Agilent Technologies, the No. 2 manufacturer of pre-printed micro-arrays, had $333 million in orders and $321 million in revenues for its Life Sciences and Chemical Analysis division, up from $303 million in orders and $298 million in revenues for the same period last year, as it returned to profitability in the fiscal fourth quarter of 2003.

Overall, the company reported revenues of $1.68 billion for the quarter, which ended Oct. 31, 2003, compared to $1.7 billion for the year-ago quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.